You are here: Industry Insights > COVID-19

News List

CSL Behring Begins Trial to Evaluate Monoclonal Antibody for Respiratory Distress americanpharmaceuticalreview
July 16, 2020
CSL Behring announced that the first patient has been enrolled in its Phase 2 study to assess the safety and efficacy of CSL312 (garadacimab, Factor XIIa antagonist monoclonal antibody) to treat patients suffering from severe respiratory distress ...
Tocilizumab lowers risk of death for critical COVID-19 patients on ventilators, finds study europeanpharmaceuticalreview
July 16, 2020
Patients who received tocilizumab in the retrospective, single-centre study were 45 percent less like to die and more likely to come off ventilation within 28 days.
Study finds fenofibrate may downgrade Covid-19 to common cold level pharmaceutical-technology
July 16, 2020
A study conducted by professor Yaakov Nahmias at Hebrew University in Israel has found that an existing cholesterol drug, fenofibrate, could ‘downgrade’ Covid-19 threat level to that of a common cold.
Hackensack Meridian partners with Merck for Covid-19 research pharmaceutical-technology
July 16, 2020
The Hackensack Meridian Center for Discovery and Innovation (CDI) has entered into a research alliance with Merck to explore drugs for the treatment of Covid-19.
Swiftly waning COVID-19 immunity poses vaccination challenge expresspharma
July 16, 2020
Preliminary studies in China, Germany, Britain and elsewhere have found that patients infected with the novel coronavirus make protective antibodies as part of their immune system’s defences, but these appear to last only a few months.
Hetero to supply 60,000 vials of generic Remdesvir from July 13 expresspharma
July 16, 2020
Out of 60,000 vials, Maharashtra, which has the highest number of COVID-19 cases in the country will get 12,500 followed by Delhi and Telangana with 10,000 and 9,000 respectively.
Gerresheimer’s global pharma business develops well during COVID-19 pandemic expresspharma
July 16, 2020
Gerresheimer generated revenues of EUR 363 million in the second quarter of 2020, marking 4.6 per cent organic growth in the core business compared to the same quarter of the prior year.
Moderna Phase 1 results show coronavirus vaccine safe, induces immune response expresspharma
July 16, 2020
Volunteers who got two doses of the vaccine had high levels of virus-killing antibodies that exceeded the average levels seen in people who had recovered from COVID-19: Moderna's research team.
AIOCD requests government to ban E-pharmacies expresspharma
July 16, 2020
The conflict between online pharmacies and offline pharmacies seems to have worsened since the outbreak of the coronavirus pandemic in the country, both sides seek government intervention.
'Prepare now for winter COVID-19 peak', says Academy of Medical Sciences pharmatimes
July 15, 2020
Experts at the Academy of Medical Sciences (AMS) are warning that the UK must prepare now for a potential new wave of coronavirus infections that could be worse than the first.